Bioterrorism alleging use of anthrax and interim guidelines for management--United States, 1998.
暂无分享,去创建一个
[1] J. D. Malone,et al. Anthrax as a potential biological warfare agent. , 1998, Archives of internal medicine.
[2] C. Fullerton,et al. The threat of biological weapons. Prophylaxis and mitigation of psychological and social consequences. , 1997, JAMA.
[3] C. Macera,et al. Health promotion practices among physicians. , 1996, American journal of preventive medicine.
[4] Philip K. Russell,et al. Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. , 1999, JAMA.
[5] J. Ezzell,et al. Postexposure prophylaxis against experimental inhalation anthrax. , 1993, The Journal of infectious diseases.
[6] T J Cieslak,et al. Clinical recognition and management of patients exposed to biological warfare agents. , 1997, Clinics in laboratory medicine.
[7] Susan N. Lukwago,et al. Physician recommendations for diet and physical activity: which patients get advised to change? , 1997, Preventive medicine.
[8] M. Hugh-jones,et al. The Sverdlovsk anthrax outbreak of 1979. , 1994, Science.
[9] D. Siscovick,et al. Physician-based diet counseling for cholesterol reduction: current practices, determinants, and strategies for improvement. , 1993, Preventive medicine.
[10] M. Meltzer,et al. The economic impact of a bioterrorist attack: are prevention and postattack intervention programs justifiable? , 1997, Emerging infectious diseases.
[11] P. Jahrling,et al. Clinical recognition and management of patients exposed to biological warfare agents. , 1997, JAMA.